Photo Credit: 2019 Novocure. All rights reserved. The U.S. Food & Drug Administration (FDA) recently approved a breakthrough treatment option for malignant pleural mesothelioma patients. Novocure’s NovoTTF-100L offers new hope, with clinical trials improving the prognosis of patients who used it with chemotherapy. It is the first new treatment option for the deadly disease to
The post What Mesothelioma Patients Should Know About the NovoTTF-100L Treatment System appeared first on Mesothelioma Help Now.
from Mesothelioma Help Now https://ift.tt/2pDNnS2
via IFTTT
What Mesothelioma Patients Should Know About the NovoTTF-100L Treatment System
![What Mesothelioma Patients Should Know About the NovoTTF-100L Treatment System]()
Reviewed by Unknown
on
November 22, 2019
Rating:
No comments: